EPISODE 29: WITH SCOTT SCHLIEBNER

VP and Global Head of Drug Development Consulting, Novotech

Scott joins Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!